CRISPR-CAS9 HSF4-targeted for clear cell renal cell carcinoma proliferation capacity, colony and tumorspheres formation / Mei Juan Wong
Clear cell renal cell carcinoma (ccRCC) is the most prevalent form of kidney cancer, accounts for about 75% of all kidney cancer cases. Although anti-angiogenic drugs targeting the receptor tyrosine kinases and mTOR inhibitors were clinically approved for ccRCC, but the current available drugs are s...
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | थीसिस |
| प्रकाशित: |
2022
|
| विषय: |